A067290 Share Price Performance
₩1,458.00
-152.48 (-9.47%)
Price ₩1,458.00
Share Price₩1,458.00
We Think You Should Be Aware Of Some Concerning Factors In JW Shinyak's (KOSDAQ:067290) Earnings
May 24
JW Shinyak Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A067290 Community Narratives
There are no narratives available yet.
Recent A067290 News & Updates
JW Shinyak Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 264.06
- Gross Margin
- 50.65%
- Net Profit Margin
- 16.16%
- Debt/Equity Ratio
- 26.8%
JW Shinyak Corporation Competitors
Snowflake Analysis
About A067290
- Founded
- 1981
- Employees
- 183
- CEO
- WebsiteView website
JW Shinyak Corporation engages in the research, development, production, and sale of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. using immune cells. JW Shinyak Corporation was founded in 1981 and is headquartered in Gwacheon-si, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.4%
- 3 Months: 13.2%
- 1 Year: 33.0%
- Year to Date: 44.6%
Over the last 7 days, the market has risen 3.4%, driven by gains of 7.2% in the Information Technology sector. As for the past 12 months, the market is up 33%. Earnings are forecast to grow by 24% annually. Market details ›